The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diabetes Mellitus and the Risk of Cancer: Results From a Large-Scale Population-Based Cohort Study in Japan
Abstract
BACKGROUND: An association between diabetes mellitus (DM) and cancer has long been speculated, but no conclusive evidence has been obtained. METHODS: We prospectively examined the association between a history of DM and subsequent risk of cancer in the Japan Public Health Center-Based Prospective Study. A total of 97 771 general Japanese persons (46 548 men and 51 223 women) aged 40 to 69 years who responded to the baseline questionnaire, from January 1990 to December 1994, were followed up for cancer incidence through December 31, 2003. At baseline, 6.7% of men and 3.1% of women had a history of DM. RESULTS: A total of 6462 cases of newly diagnosed cancer were identified. In men, a 27% increase in the risk of total cancer incidence was observed in those with a history of DM (n = 3907 [366 with DM]; hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.14-1.42). The HR was especially high for those with cancer of the liver (n = 312 [52 with DM]; HR, 2.24; 95% CI, 1.64-3.04), pancreas (n = 118 [16 with DM]; HR, 1.85; 95% CI, 1.07-3.20), and kidney (n = 99 [13 with DM]; HR, 1.92; 95% CI, 1.06-3.46). We also observed a moderately increased risk of colon cancer (n = 491 [46 with DM]; HR, 1.36; 95% CI, 1.00-1.85) and of stomach cancer with borderline significance (n = 977 [87 with DM]; HR, 1.23; 95% CI, 0.98-1.54). In women, a borderline significant increase in risk was observed for the incidence of total cancer (n = 2555 [104 with DM]; HR, 1.21; 95% CI, 0.99-1.47), while statistical significance was observed for the incidence of stomach cancer (n = 362 [20 with DM]; HR, 1.61; 95% CI, 1.02-2.54) and liver cancer (n = 120 [10 with DM]; HR, 1.94; 95% CI, 1.00-3.73) and borderline significance was observed for the incidence of ovarian cancer (n = 74 [5 with DM]; HR, 2.42; 95% CI, 0.96-6.09). CONCLUSION: Patients with DM drawn from the general Japanese population may be at increased risk of total cancer and of cancer in specific sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying mechanisms of tumorigenesis in T2DM seem to be related to insulin resistance, hyperinsulinemia, elevated levels of IGF-1 [140-142], and hyperglycemia with the latter driving ATP production in cancer cells through the glycolytic pathway, a mechanism known as the Warburg effect [142].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [140]
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 989
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 852
Giovannucci, E. L. (1995) · Cancer Causes & Control · doi:10.1007/bf00052777 · Cited by 808
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J. M., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Cited by
Sorted by citations
Items 501–562 of 562
Aspetti epidemiologici delle neoplasie nel diabete
Nicolucci, A. (2007) · L Endocrinologo · doi:10.1007/bf03344578
Nutritional Prevention Of Colorectal Cancer: Attitudes And Practices Of Primary Care Providers
Dykstra, A. J. (2014) · UA Campus Repository (The University of Arizona)
Hypoglycemia and other complications of insulin therapy
Amiel, S. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch53
Implications of Type II Diabetes Mellitus on Gastrointestinal Cancers
Diana, H., & Mazen, M. (2011) · InTech eBooks · doi:10.5772/22303
Aspects épidémiologiques de l’association diabète et cancer
Simon, D. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70180-8
Gordon-Dseagu, V. (2014) · UCL Discovery (University College London)
The role of Src kinase in renal cell carcinoma
Qayyum, T. (2014) · Enlighten: Theses (The University of Glasgow)
Pourquoi les diabétiques ont-ils un risque plus important de développer un cancer ?
Buysschaert, M. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70836-3
Suceveanu, A., Mazilu, L., Voinea, F., Suceveanu, A. P., Parepa, I. R., Catrinoiu, D., & Tuta, L. A. (2013) · Ars medica tomitana · doi:10.2478/arsm-2013-0009
Cancers du pancréas et sécurité des incrétines : état des lieux en 2014
Halimi, S. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70835-1
Johnson, J. A., & Bowker, S. L. (2011) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-011-0017-4
Durlach, V. (2011) · Médecine thérapeutique · doi:10.1684/met.2011.0332
Obésité et risque de cancer digestif
Hillon, P., & Hamza, S. (2012) · Hépato-Gastro & Oncologie Digestive · doi:10.1684/hpg.2012.0694
Controversy regarding gastric cancer and diabetes
Fujishiro, M., & Ishihara, H. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1113-9
Association Between Glucose Tolerance Level and Cancer Death in a General
Hirakawa, Y., Ninomiya, T., Mukai, N., Doi, Y., Hata, J., Fukuhara, M., Iwase, M., Kitazono, T., & Kiyohara, Y. (2012)
Changes in Clinical Characteristics of Non-B, Non-C Hepatocellular Carcinoma
Ishii, T., SUZUKI, M. T., Matsumoto, N., Yamada, N., Okamoto, M., Ikeda, H., Kobayashi, M., Takahashi, H., Katakura, Y., Matsunaga, K., et al. (2008)
Expressão do receptor do peptídeo liberador da gastrina em câncer hepatocelular
Lazaretti, N. S. (2010) · Americanae (AECID Library)
Contribution of hepatologists for the early detection of nonB-nonC HCC
Ohyama, A., Kariyama, K., Nouso, K., Oonishi, A., Wakuta, A., Nishimura, M., & Higashi, T. (2014) · Kanzo · doi:10.2957/kanzo.55.284
Metformin and its use in chronic kidney disease, cardiovascular disease and cancer
Sultana, R.-R., & Rice, S. (2015) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738014563996
Hepatic and Extrahepatic Malignancies in NAFLD
Nascimbeni, F., & Ratziu, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_14
The Associations of Diabetes with Digestive, Oral, and Liver Disease, and Autonomic Neuropathy
Clark, J. M., Gibbons, C. H., & Mustapha, I. Z. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195317060.003.0012
2) Diabetes and Its Treatment and Cancer
Noda, M., Goto, A., & Noto, H. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.1897
Mizoue, T., Goto, A., Takahashi, Y., Matsushita, Y., Nanri, A., Iso, H., Inoue, M., & Tsugane, S. (2015)
Self-citationType 2 diabetes mellitus (T2DM) onset and "remission".
Tangelloju, S. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2515
アミノインデックス Ⓡ がんリスクスクリーニング(AICS Ⓡ )ランクと生活習慣との関連性
山本, 浩., 麻以, 山., 石坂, 裕., 菊池信矢, 新美, 佑., 谷, 瑞., & 山門, 實. (2018) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.33.440
Krajewska, J., Krajewski, W. R., & Zatoński, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_59
Bae, J. (2019) · Journal of Urologic Oncology · doi:10.22465/kjuo.2019.17.3.119
Analysis of the association of diabetes mellitus with cancer using autopsy records
Wada, R., Kimura, S., Kure, S., Ishino, K., Kudo, M., & Naito, Z. (2020) · World Academy of Sciences Journal · doi:10.3892/wasj.2020.52
Guillen, J. K. (2020) · ScholarSpace (University of Hawaii at Manoa)
Cornelli, U., Giovanni, B., & Martino, R. (2020) · Journal of Medical - Clinical Research & Reviews · doi:10.33425/2639-944x.1127
Yamasaki, S. (2011) · Japanese Journal of Health Promotion and Physical Therapy · doi:10.9759/hppt.1.3
안젬마, & 이종균 (2013)
Association between Diabetes and Controlling Risk Factors with Survival Rate in Colorectal Cancer
Nasab, M. S., Yazdimoghaddam, H., Mohaddes, S. T., & Rakhshani, M. H. (2021) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.30.e56391
Effective Preventive Care Management of Multiple Chronic ConditionsPreprint
Hajjar, A., & Alagöz, O. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3398415
Rais‐Bahrami, S., & Moreira, D. M. (2012) · Urology · doi:10.1016/j.urology.2012.01.071
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Neel, B. A., Antoniou, I. M., & LeRoith, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_36-1
Cheng, B., Han, X., Wan, H., Sun, Z., & Wang, W. (2022) · Research Square · doi:10.21203/rs.3.rs-1919785/v1
Atef, M., Eletreby, R., Abdallah, M., Salama, R. A. A., Elakel, W., Hassany, M., Abdel‐Razek, W., Shazly, Y. E., Doss, W. H., & Esmat, G. (2022) · Egyptian Liver Journal · doi:10.1186/s43066-022-00213-z
Enhanced degradation of epidermal growth factor receptor by metformin
Yamagata, M., Higashi, S., Noboru, Y., Ichihara, A., Habu, M., Sasaguri, M., Tominaga, K., & Takeuchi, H. (2023) · Oral Science International · doi:10.1002/osi2.1179
Wojciechowska, J. K., Krajewski, W. R., Zatoński, T., & Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_63
Waterworth, A., Hamilton, A. C., Johnston, P. C., Todd, A., Connolly, G. M., Nugent, A. G., Scullin, P., McKenna, S., Lawless, S., Wallace, H. J., et al. (2023) · Practical Diabetes · doi:10.1002/pdi.2456
Correlation between Diabetes and Diabetic Retinopathy and Cancer RiskPreprint
Chang, W., Hsieh, T., Hsu, W. L., Chang, F.-L., & He, M.-S. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4564674
Han, K. H., Choi, Y. J., Kim, T. I., Park, N. H., Han, K., & Lee, D. H. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4569055
Li, J., Wang, R., Zhang, J., Cheng, B., Zhan, S., Li, C., Xiong, S., Yan, Z., Chi, W., Liu, B., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4604773
RISK FACTORS FOR THE DEVELOPMENT OF GASTRIC CANCER: A SINGLE CENTER EXPERIENCE
Rančić, A., Brzački, V., Popović, A., & Topalović, M. (2023) · Acta Medica Medianae · doi:10.5633/amm.2023.0104
Daniel, J. M. M., Mathiazhagan, G., & Sathick, I. J. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_18
Hansen, K., Peters, K., Burkert, C. K., Brose, E., Calvisi, D. F., Ehricke, K., Engeler, M., Knuth, E., Kröger, N., Löhr, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111438
Wu, Y., Yao, Z., Wang, Y., Lou, Y., Tu-gen, Y., Chen, R., Shou, X., & Gu, W. (2024) · Clinical Endocrinology · doi:10.1111/cen.15161
Cirrhose métabolique : une entité en plein essor
Ratziu, V. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.11.012
Role of Financial Markets in Climate Change Adaptation and Mitigation
Selvakumar, P., Prabakaran, Manjunath, T. C., Riyazuddin, Gayathri, M., & Kanagaraj, A. R. K. A. R. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-6766-8.ch011
Ma, Z., Lin, Y., Zhang, B., Yue, P., Li, B., & Meng, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-30485-5
Ghadirzadeh, B., Assadi, S., Moradveisi, B., & Moradi, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02041-8
Tawfik, M. E.-R., & Elsawy, A. A. (2015) · Hepatoma Research · doi:10.4103/2394-5079.154356
Liu, J., Wang, R., Tan, S., Zhao, X., & Hou, A. (2024) · Figshare · doi:10.6084/m9.figshare.26691607
Zeng, X., Li, Z., 林, 乐., & Wei, X. (2024) · Figshare · doi:10.6084/m9.figshare.26301152
Zeng, X., Li, Z., 林, 乐., & Wei, X. (2024) · Figshare · doi:10.6084/m9.figshare.26301221
New radiomics approaches for hepatic tumor characterization through imaging analysis
Ouhmich, F. (2021) · theses.fr (ABES) · doi:10.70675/b5d050c9zbcc8z4ba2z8e59z8b953b2cebea
Coimbra, F. J. F., de Godoy, A. L., Fernandes, P. H. D. S., Neto, H. F. E. C., Pinheiro, R. N., Boin, I. D. F. S. F., Andraus, W., Tustumi, F., AMARAL, P. C. G., Brandão‐Mello, C. E., et al. (2026) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-672020260000018e1947
Yoshikawa, A., Okita, K., Tsuneda, K., Fujita, S., Takahara, M., Kozawa, J., Watanabe, N., Shimomura, I., & Kawata, S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113449
AlBreacan, L. M., Jnaid, H., Arai, M., & Helaly, Z. (2026) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2252_25
Insulin Resistance and Hepatocarcinogenesis
Sasaki, H., & Sasaki, Y. (2010) · Institutional Repositories DataBase (IRDB)
Metadata
- Authors
- Inoue, M.
- Affiliations
- National Cancer Centre Japan (JP)
- Corresponding author
- Inoue, Manami
- ORCID
- Inoue, Manami
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1871
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2096623507
- Cited by
- 561
- References
- 59
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 28 · 2019: 29 · 2018: 22 · 2017: 35 · 2016: 22 · 2015: 31 · 2014: 41 · 2013: 51 · 2012: 55
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- diabetes mellitus, cancer risk, cancer incidence, liver cancer, pancreatic cancer, kidney cancer, colon cancer, gastric cancer, sex differences, Japan Public Health Center-based Prospective Study, Japanese adults, prospective cohort, hazard ratio, cancer mortality, cancer prevention, lifestyle modification, cancer survivorship, cancer survivorship support services
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Digestive System Neoplasms, Female, Humans, Japan, Male, Middle Aged, Neoplasms, Prospective Studies, Risk Factors, Incidence, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review